tetano
Editor, Senior Moderator
J Neurosurg Anesthesiol. 2020 Apr 8. doi: 10.1097/ANA.0000000000000688. [Epub ahead of print]
Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC)_Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), and European Society of Minimally Invasive Neurological Therapy (ESMINT).
Sharma D[SUP]1[/SUP], Rasmussen M[SUP]2[/SUP], Han R[SUP]3[/SUP], Whalin M[SUP]4[/SUP], Davis M[SUP]5[/SUP], Kofke WA[SUP]6[/SUP], Raghvan LV[SUP]7[/SUP], Raychev R[SUP]8[/SUP], Fraser JF[SUP]9[/SUP].
Author information
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has unique implications for the anesthetic management of endovascular therapy for acute ischemic stroke. The Society for Neuroscience in Anesthesiology and Critical Care appointed a task force to provide timely, consensus-based expert recommendations using available evidence for the safe and effective anesthetic management of endovascular therapy for acute ischemic stroke during the COVID-19 pandemic. The goal of this consensus statement is to provide recommendations for anesthetic management considering: (1) optimal neurological outcomes for patients; (2) minimizing the risk for healthcare professionals, and (3) facilitating judicious use of resources while accounting for existing variability in care. It provides a framework for selecting optimal anesthetic technique (general anesthesia or monitored anesthesia care) for a given patient and offers suggestions for best practices for anesthesia care during the pandemic. Institutions and healthcare providers are encouraged to adapt these recommendations to best suit local needs, considering existing practice standards and resource availability to ensure safety of patients and providers.
PMID:32282614DOI:10.1097/ANA.0000000000000688
Anesthetic Management of Endovascular Treatment of Acute Ischemic Stroke During COVID-19 Pandemic: Consensus Statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC)_Endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), and European Society of Minimally Invasive Neurological Therapy (ESMINT).
Sharma D[SUP]1[/SUP], Rasmussen M[SUP]2[/SUP], Han R[SUP]3[/SUP], Whalin M[SUP]4[/SUP], Davis M[SUP]5[/SUP], Kofke WA[SUP]6[/SUP], Raghvan LV[SUP]7[/SUP], Raychev R[SUP]8[/SUP], Fraser JF[SUP]9[/SUP].
Author information
Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has unique implications for the anesthetic management of endovascular therapy for acute ischemic stroke. The Society for Neuroscience in Anesthesiology and Critical Care appointed a task force to provide timely, consensus-based expert recommendations using available evidence for the safe and effective anesthetic management of endovascular therapy for acute ischemic stroke during the COVID-19 pandemic. The goal of this consensus statement is to provide recommendations for anesthetic management considering: (1) optimal neurological outcomes for patients; (2) minimizing the risk for healthcare professionals, and (3) facilitating judicious use of resources while accounting for existing variability in care. It provides a framework for selecting optimal anesthetic technique (general anesthesia or monitored anesthesia care) for a given patient and offers suggestions for best practices for anesthesia care during the pandemic. Institutions and healthcare providers are encouraged to adapt these recommendations to best suit local needs, considering existing practice standards and resource availability to ensure safety of patients and providers.
PMID:32282614DOI:10.1097/ANA.0000000000000688